Football once again centre stage for Tangney after Covid nightmare hoganstand.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hoganstand.com Daily Mail and Mail on Sunday newspapers.
A new study being led by the University of Birmingham, University Hospitals Birmingham NHS Foundation Trust, and University College London aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody def
New study will explore Covid immune response in patients with antibody deficiency
The study aims to explore Covid-19 immune response in patients with antibody deficiencies (Jacob King/PA)
A new study will look at the immune response to natural coronavirus infection and vaccination in patients with antibody deficiency.
The Covid infection in patients with Antibody Deficiency (COVAD) study is part of a group of national studies examining the immune responses in patients considered at high risk of Covid-19.
Immunodeficiency patients are considered vulnerable or extremely vulnerable to the virus and have had to undertake preventative measures to minimise their risk of exposure to the virus, including shielding.
Share This
The FINANCIAL COVID infection in patients with antibody deficiency (COVAD) is part of a portfolio of national studies examining the immune responses in patients at high risk of COVID-19.
A new study, funded by UK Research and Innovation, aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency. The study is being led by:
University of Birmingham
University College London.
Vulnerable patients
Immunodeficiency patients are considered vulnerable or extremely vulnerable to COVID-19 infection and have had to undertake preventative measures to minimise their risk of exposure to the virus according to UKRI.